516

THE 2021 EVER FESTIVAL
Science for Sight

THE 2021 EVER FESTIVAL
Science for Sight

 Zum Kalender hinzufügen
 Veranstaltung teilen
 Zur Merkliste hinzufügen
Datum
02.10.2021
Fortbildung
Online
Sprache
Englisch
Gebühren ab
30.00 EUR
Veranstalter
EVER SECRETARY - European Association for Vision and Eye Research
c/o OIC Group srl (Organizzazione Internazionale Congressi)
Organisator

EVER SECRETARY - European Association for Vision and Eye Research
c/o OIC Group srl (Organizzazione Internazionale Congressi)
Via G. Matteotti 7
IT - 50121 Firenze

Tel.: +39 055 5035265

The EVER congresses focus on future developments in Eye Research. Younger scientists at the PhD or residency level are specifically welcome to present their data. Topics include lectures, discussions, poster sessions and rapid fire presentations.
Encouraged by the success of last year’s EVER Virtual Library, the Programme Secretary and the EVER Board have developed a new programme which will consist of: EVER 2021 Virtual Congress.
  • Basisinformation
    Datum
    02.10.2021
    Fortbildung
    Online
    Sprache
    Englisch
    Gebühren ab
    30.00 EUR
    Veranstalter
    EVER SECRETARY - European Association for Vision and Eye Research
    c/o OIC Group srl (Organizzazione Internazionale Congressi)
    Organisator

    EVER SECRETARY - European Association for Vision and Eye Research
    c/o OIC Group srl (Organizzazione Internazionale Congressi)
    Via G. Matteotti 7
    IT - 50121 Firenze

    Tel.: +39 055 5035265

  • VERANSTALTUNGSORT

  • Programm
    09:30-10:25 Session 1
    Moderator: Dominique Bremond-Gignac, France
    09:30 ACB Surgical aspects of RPE cell therapy for AMD
    Boris V. Stanzel, Germany
    09:40 COS Advances and Innovations in Eye Banking and Tissue Processing for Corneal Transplantation
    Zisis Gatzioufas, Switzerland
    09:50 EOVS Contribution of adaptive optics ophthalmoscopy to the investigation of the Stiles-Crawford effect in retinal diseases
    Michel Paques, France
    10:00 G Gene therapy for optic nerve protection and repair Keith Martin, Australia
    10:10   LIVE Q & A
    10:30-11:25 Session 2
    Moderator: Manuel Vidal-Sanz, Spain
    10:30 IM Cutting-edge imaging for Uveitis
    Francesco Pichi, Italy
    10:40 LC Corneal Regeneration: Is it possible?
    Jorge Alio, Spain
    10:50 MBGE MicroRNA-mRNA genetic networks in refractive eye development and myopia
    Andrei V. Tkatchenko, United States
    11:00 NSPH Optic Neuritis and Anti-What?: The NMO and MOG story
    John J. Chen, United States
    11:10   LIVE Q & A
    11:30-12:15 Session 3
    Moderator: Frédéric Mouriaux, France
    11:30 PO MR Imaging of Uveal Melanoma with Clinicopathological Correlations Teresa Ferreira, Netherlands
    11:40 PBV Retinal energy metabolism in vascular and avascular retinas Glyn Chidlow, United States
    11:50 RV Venous Overload Choroidopathy: Associated Conditions Richard F. Spaide, United States
    12:00   LIVE Q & A
    12:15-13:00 Industry Lunch Symposium
    13:00-13:45 Industry Lunch Symposium
    14:00-14:45 Session 4 - Rapid Fire
    Moderators: Kai Kaarniranta, Finland, & Marcela Votruba, United Kingdom
    14:00 ACB Phloretin reduced the secretion of IL-8 in retinal pigment epithelial cells suffering from mitochondrial dysfunction via activation of nuclear factor erythroid 2 related factor 2 (NFE2L2/Nrf2)
    Maria Hytti, Finland
    14:05 COS A unique pre-endothelial layer at the posterior peripheral cornea: Ultra-structural study
    Saeed Akhtar, Saudi Arabia
    14:10 EOVS Neuronal sources of visually evoked potentials using selective color opponent channel stimulation
    Sascha Klee, Germany
    14:15 G Multivariate normative comparison, a novel method for improved use of the retinal nerve fiber layer thickness to detect early glaucoma
    Jacqueline Chua, Singapore
    14:20 IM Vision-related quality of life in spondyloarthritis patients with history of acute anterior uveitis under treatment with golimumab: preliminary results of the GO-VISION observational stud
    Ines Leal, Portugal
    14:25 LC A comparative study of difluprednate 0.05% Nanoemulsion vs prednisolone acetate 1% + phenylephrine 0.12% Suspension on postoperative inflammation treatment following cataract surgery
    Melina Sol del Papa, Argentina
    14:30    LIVE Q & A
    14:50-15:30 Session 5 - Rapid Fire
    Moderators: Manuel Vidal-Sanz, Spain, Roy Andrew Quinlan, United Kingdom
    14:50 MBGE Pharmacogenetics. Phenotype And Genotype Response To Prostaglandin Analogues And Beta Bloquers In A Population Of Glaucoma  Patients Valeria Opazo Toro, Spain
    14:55  NSPH  Retina Analysis With Optical Coherence Tomography In Patients With Fibromyalgia Beatriz Cordón Ciordia, Spain
    15:00  PO  The effects of visible and blue light exposure on growth and melanogenesis of ocular melanoma cell lines Chieh-Lin (Stanley) Wu, Australia
    15:05  PBV  Ten differentially expressed proteins in the tear film of dogs with diabetic retinopathy Dagmara Winiarczyk, Poland
    15:10  RV  Comparison of quantitative self-monitoring metamorphopsia measurements tools in myopic choroidal neovascularization (mCNV) Katja Hatz, Switzerland
    15:15   LIVE Q & A
    15:35-16:15 Session 6 - Young Investigators
    Moderators: João Barbosa Breda, Portugal, Francesca Cordeiro, United Kingdom
    15:35 ACB Effect of systemic immunosupression and BM-MSC allotransplantation in retinal functionality and RGC population
    María Norte Muñoz, Spain
    15:40  COS  Dendritic cell depletion modifies corneal nerve activity and mice nociceptive behaviour
    Laura Rincon Frutos, Spain
    15:45  EOVS  Evaluation of the effect of eye movements on the Sweep VEP
    Ioannis Dimopoulos, Canada
    15:50 G Glaucoma clinical research: Trends in treatment strategies and drug discovery
    Josefine Clement Freiberg, Denmark
    15:55 IM Cytokine profile in tear and aqueous humor of primary open-angle glaucoma patients as a prognostic factor for trabeculectomy outcome
    Barbara Burgos-Blasco, Spain
    16:00 LC Spontaneous Lens Subluxation Into Anterior Chamber. Importance Of An Early Management
    Ismael Bakkali El Bakkali, Spain
    16:05   LIVE Q & A
    16:20-16:55 Session 7 - Young Investigators
    Moderator: Dominique Bremond-Gignac, France
    16:20 MBGE Effects of Inhibition of Wnt/beta-catenin Pathway on Amacrine and Muller cells in Retinas of Zebrafish Embryos at Different Development Stages Ayse Ipek Akyuz Unsal, Turkey
    16:25 NSPH Retinal Neurodegeneration And Neuroinflamation In A Sod1 Mouse Model Of Als María Pilar Rojas Lozano, Spain
    16:30 PO Radiological work-up for proton beam therapy of uveal melanoma patients Myriam Jaarsma-Coes, Netherlands
    16:35 PBV Decreased docosahexaenoic acid and other specific fatty acids in a mouse model of retinal degeneration María José Ruiz Pastor, Spain
    16:40 RV Identification of eleven differentially expressed proteins in the tear film of patients with neovascular Age-related Macular Degeneration (AMD) Mateusz Winiarczyk, Poland
    16:45   LIVE Q & A
    17:00-17:10 AWARDS
    17:10-17:40 GENERAL ASSEMBLY

    ACB = Anatomy/Cell Biology; COS = Cornea/Ocular Surface; EOVS = Electrophysiology, Physiological Optics, Vision Sciences; G = Glaucoma;
    IM = Immunology/Microbiology; LC = Lens and Cataract; MBGE = Molecular Biology/Genetics/Epidemiology;
    NSPH = Neuro-ophthalmology/Strabismology/Paediatric Ophthalmology/History of Ophthalmology; PO = Pathology/Oncology;
    PBP = Physiology/Biochemistry/Pharmacology; RV = Retina/Vitreous Section programme secretaries

    Deadlines
    Abstract
    30.07.2021    		Hinweis
    The presenter needs to be registered to the 2021 EVER Festival within 30 August 2021.
  • Gebühren
    alle
    Gebühren ab
    30,00 EUR
    EVER Full Member: 30,00€
    EVER Low Income Country Member: 30,00€
    EVER Member in training: 30,00€
    Non Member: 150,00€
    Registration fees to the 2021 EVER Festival include:
    EVER virtual library access (27. September - 2. October 2021)
    EVER
  • Buchung / Anmeldung

    Please contact the organizer for further information.

    You are the organizer?
    Would you like to link your online registration here?
    Please contact our sales team for an individual offer:
    +49 (0) 30 920 385 42 62 (phone)
    info@eyefox.com (e-mail).

  • Zertifizierung
    Keine Zertifizierung beantragt
  • Sponsoren
    Allergan France
    Horus Pharma
    Théa Laboratoires (FR)
    Chiesi GmbH

Veranstaltung teilen

Kontakt zu EYEFOX

+49 (30) 4036 422 - 0

info@eyefox.com